Figure 5 from Integrated Multimodal Analyses of DNA Damage Response and Immune Markers as Predictors of Response in Metastatic Triple-Negative Breast Cancer in the TNT Trial (NCT00532727) Article Swipe
Holly Tovey
,
Orsolya Sipos
,
Joel S. Parker
,
Katherine A. Hoadley
,
Jelmar Quist
,
Sarah Kernaghan
,
Lucy Kilburn
,
Roberto Salgado
,
Sherene Loi
,
Richard D. Kennedy
,
Ioannis Roxanis
,
Patrycja Gazińska
,
Sarah E. Pinder
,
Judith M. Bliss
,
Charles M. Perou
,
Syed Haider
,
Anita Grigoriadis
,
Andrew Tutt
,
Maggie C.U. Cheang
·
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.1158/1078-0432.24145967.v1
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.1158/1078-0432.24145967.v1
Results of a novel clustering. A, Response rates by novel clusters and treatment groups. P values are presented from Fisher exact tests. Clusters 4 and 6 are not shown due to small numbers. B, Heatmap showing biological features of each novel cluster. PGA, percentage of genome altered; SI, Shannon diversity index; NtAI, number of telomeric allelic imbalances; AiCna, allelic imbalanced CNA; AbCna, allelic balanced CNA; CnLOH, copy number neutral loss of heterozygosity.
Related Topics
Concepts
Loss of heterozygosity
Allele
Genetics
Biology
Breast cancer
Immune system
Triple-negative breast cancer
Cancer research
Cancer
Molecular biology
Gene
Metadata
- Type
- preprint
- Language
- en
- Landing Page
- https://doi.org/10.1158/1078-0432.24145967.v1
- OA Status
- gold
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4386778139
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4386778139Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1158/1078-0432.24145967.v1Digital Object Identifier
- Title
-
Figure 5 from Integrated Multimodal Analyses of DNA Damage Response and Immune Markers as Predictors of Response in Metastatic Triple-Negative Breast Cancer in the TNT Trial (NCT00532727)Work title
- Type
-
preprintOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2023Year of publication
- Publication date
-
2023-09-15Full publication date if available
- Authors
-
Holly Tovey, Orsolya Sipos, Joel S. Parker, Katherine A. Hoadley, Jelmar Quist, Sarah Kernaghan, Lucy Kilburn, Roberto Salgado, Sherene Loi, Richard D. Kennedy, Ioannis Roxanis, Patrycja Gazińska, Sarah E. Pinder, Judith M. Bliss, Charles M. Perou, Syed Haider, Anita Grigoriadis, Andrew Tutt, Maggie C.U. CheangList of authors in order
- Landing page
-
https://doi.org/10.1158/1078-0432.24145967.v1Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://doi.org/10.1158/1078-0432.24145967.v1Direct OA link when available
- Concepts
-
Loss of heterozygosity, Allele, Genetics, Biology, Breast cancer, Immune system, Triple-negative breast cancer, Cancer research, Cancer, Molecular biology, GeneTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
0Total citation count in OpenAlex
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4386778139 |
|---|---|
| doi | https://doi.org/10.1158/1078-0432.24145967.v1 |
| ids.doi | https://doi.org/10.1158/1078-0432.24145967.v1 |
| ids.openalex | https://openalex.org/W4386778139 |
| fwci | 0.0 |
| type | preprint |
| title | Figure 5 from Integrated Multimodal Analyses of DNA Damage Response and Immune Markers as Predictors of Response in Metastatic Triple-Negative Breast Cancer in the TNT Trial (NCT00532727) |
| biblio.issue | |
| biblio.volume | |
| biblio.last_page | |
| biblio.first_page | |
| topics[0].id | https://openalex.org/T11287 |
| topics[0].field.id | https://openalex.org/fields/13 |
| topics[0].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[0].score | 0.9793999791145325 |
| topics[0].domain.id | https://openalex.org/domains/1 |
| topics[0].domain.display_name | Life Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/1306 |
| topics[0].subfield.display_name | Cancer Research |
| topics[0].display_name | Cancer Genomics and Diagnostics |
| topics[1].id | https://openalex.org/T10417 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9545000195503235 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2740 |
| topics[1].subfield.display_name | Pulmonary and Respiratory Medicine |
| topics[1].display_name | Lung Cancer Treatments and Mutations |
| topics[2].id | https://openalex.org/T11395 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9361000061035156 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2741 |
| topics[2].subfield.display_name | Radiology, Nuclear Medicine and Imaging |
| topics[2].display_name | Radiopharmaceutical Chemistry and Applications |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C143589142 |
| concepts[0].level | 4 |
| concepts[0].score | 0.8097221851348877 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q2617554 |
| concepts[0].display_name | Loss of heterozygosity |
| concepts[1].id | https://openalex.org/C180754005 |
| concepts[1].level | 3 |
| concepts[1].score | 0.5253949761390686 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q80726 |
| concepts[1].display_name | Allele |
| concepts[2].id | https://openalex.org/C54355233 |
| concepts[2].level | 1 |
| concepts[2].score | 0.4944794178009033 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q7162 |
| concepts[2].display_name | Genetics |
| concepts[3].id | https://openalex.org/C86803240 |
| concepts[3].level | 0 |
| concepts[3].score | 0.48784327507019043 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q420 |
| concepts[3].display_name | Biology |
| concepts[4].id | https://openalex.org/C530470458 |
| concepts[4].level | 3 |
| concepts[4].score | 0.4624078571796417 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q128581 |
| concepts[4].display_name | Breast cancer |
| concepts[5].id | https://openalex.org/C8891405 |
| concepts[5].level | 2 |
| concepts[5].score | 0.45517614483833313 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q1059 |
| concepts[5].display_name | Immune system |
| concepts[6].id | https://openalex.org/C2780110267 |
| concepts[6].level | 4 |
| concepts[6].score | 0.4408147931098938 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q7843332 |
| concepts[6].display_name | Triple-negative breast cancer |
| concepts[7].id | https://openalex.org/C502942594 |
| concepts[7].level | 1 |
| concepts[7].score | 0.4031684398651123 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q3421914 |
| concepts[7].display_name | Cancer research |
| concepts[8].id | https://openalex.org/C121608353 |
| concepts[8].level | 2 |
| concepts[8].score | 0.3782913088798523 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q12078 |
| concepts[8].display_name | Cancer |
| concepts[9].id | https://openalex.org/C153911025 |
| concepts[9].level | 1 |
| concepts[9].score | 0.3616786599159241 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q7202 |
| concepts[9].display_name | Molecular biology |
| concepts[10].id | https://openalex.org/C104317684 |
| concepts[10].level | 2 |
| concepts[10].score | 0.140337735414505 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q7187 |
| concepts[10].display_name | Gene |
| keywords[0].id | https://openalex.org/keywords/loss-of-heterozygosity |
| keywords[0].score | 0.8097221851348877 |
| keywords[0].display_name | Loss of heterozygosity |
| keywords[1].id | https://openalex.org/keywords/allele |
| keywords[1].score | 0.5253949761390686 |
| keywords[1].display_name | Allele |
| keywords[2].id | https://openalex.org/keywords/genetics |
| keywords[2].score | 0.4944794178009033 |
| keywords[2].display_name | Genetics |
| keywords[3].id | https://openalex.org/keywords/biology |
| keywords[3].score | 0.48784327507019043 |
| keywords[3].display_name | Biology |
| keywords[4].id | https://openalex.org/keywords/breast-cancer |
| keywords[4].score | 0.4624078571796417 |
| keywords[4].display_name | Breast cancer |
| keywords[5].id | https://openalex.org/keywords/immune-system |
| keywords[5].score | 0.45517614483833313 |
| keywords[5].display_name | Immune system |
| keywords[6].id | https://openalex.org/keywords/triple-negative-breast-cancer |
| keywords[6].score | 0.4408147931098938 |
| keywords[6].display_name | Triple-negative breast cancer |
| keywords[7].id | https://openalex.org/keywords/cancer-research |
| keywords[7].score | 0.4031684398651123 |
| keywords[7].display_name | Cancer research |
| keywords[8].id | https://openalex.org/keywords/cancer |
| keywords[8].score | 0.3782913088798523 |
| keywords[8].display_name | Cancer |
| keywords[9].id | https://openalex.org/keywords/molecular-biology |
| keywords[9].score | 0.3616786599159241 |
| keywords[9].display_name | Molecular biology |
| keywords[10].id | https://openalex.org/keywords/gene |
| keywords[10].score | 0.140337735414505 |
| keywords[10].display_name | Gene |
| language | en |
| locations[0].id | doi:10.1158/1078-0432.24145967.v1 |
| locations[0].is_oa | True |
| locations[0].source | |
| locations[0].license | cc-by |
| locations[0].pdf_url | |
| locations[0].version | acceptedVersion |
| locations[0].raw_type | posted-content |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | False |
| locations[0].raw_source_name | |
| locations[0].landing_page_url | https://doi.org/10.1158/1078-0432.24145967.v1 |
| locations[1].id | pmh:oai:figshare.com:article/24145967 |
| locations[1].is_oa | True |
| locations[1].source.id | https://openalex.org/S4306400572 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | OPAL (Open@LaTrobe) (La Trobe University) |
| locations[1].source.host_organization | https://openalex.org/I196829312 |
| locations[1].source.host_organization_name | La Trobe University |
| locations[1].source.host_organization_lineage | https://openalex.org/I196829312 |
| locations[1].license | cc-by |
| locations[1].pdf_url | |
| locations[1].version | submittedVersion |
| locations[1].raw_type | Image |
| locations[1].license_id | https://openalex.org/licenses/cc-by |
| locations[1].is_accepted | False |
| locations[1].is_published | False |
| locations[1].raw_source_name | |
| locations[1].landing_page_url | https://figshare.com/articles/figure/Figure_5_from_Integrated_Multimodal_Analyses_of_DNA_Damage_Response_and_Immune_Markers_as_Predictors_of_Response_in_Metastatic_Triple-Negative_Breast_Cancer_in_the_TNT_Trial_NCT00532727_/24145967 |
| indexed_in | crossref |
| authorships[0].author.id | https://openalex.org/A5020610052 |
| authorships[0].author.orcid | https://orcid.org/0000-0002-8324-0055 |
| authorships[0].author.display_name | Holly Tovey |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Holly Tovey |
| authorships[0].is_corresponding | False |
| authorships[1].author.id | https://openalex.org/A5023247455 |
| authorships[1].author.orcid | https://orcid.org/0000-0002-2762-1435 |
| authorships[1].author.display_name | Orsolya Sipos |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Orsolya Sipos |
| authorships[1].is_corresponding | False |
| authorships[2].author.id | https://openalex.org/A5054811851 |
| authorships[2].author.orcid | https://orcid.org/0000-0003-2080-6901 |
| authorships[2].author.display_name | Joel S. Parker |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Joel S. Parker |
| authorships[2].is_corresponding | False |
| authorships[3].author.id | https://openalex.org/A5002773659 |
| authorships[3].author.orcid | https://orcid.org/0000-0002-1216-477X |
| authorships[3].author.display_name | Katherine A. Hoadley |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Katherine A. Hoadley |
| authorships[3].is_corresponding | False |
| authorships[4].author.id | https://openalex.org/A5048636641 |
| authorships[4].author.orcid | https://orcid.org/0000-0003-3071-3776 |
| authorships[4].author.display_name | Jelmar Quist |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Jelmar Quist |
| authorships[4].is_corresponding | False |
| authorships[5].author.id | https://openalex.org/A5060130360 |
| authorships[5].author.orcid | https://orcid.org/0009-0003-1379-388X |
| authorships[5].author.display_name | Sarah Kernaghan |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Sarah Kernaghan |
| authorships[5].is_corresponding | False |
| authorships[6].author.id | https://openalex.org/A5057465917 |
| authorships[6].author.orcid | https://orcid.org/0000-0002-1987-7545 |
| authorships[6].author.display_name | Lucy Kilburn |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Lucy Kilburn |
| authorships[6].is_corresponding | False |
| authorships[7].author.id | https://openalex.org/A5016015665 |
| authorships[7].author.orcid | https://orcid.org/0000-0002-1110-3801 |
| authorships[7].author.display_name | Roberto Salgado |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Roberto Salgado |
| authorships[7].is_corresponding | False |
| authorships[8].author.id | https://openalex.org/A5010278367 |
| authorships[8].author.orcid | https://orcid.org/0000-0001-6137-9171 |
| authorships[8].author.display_name | Sherene Loi |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Sherene Loi |
| authorships[8].is_corresponding | False |
| authorships[9].author.id | https://openalex.org/A5088266020 |
| authorships[9].author.orcid | https://orcid.org/0000-0003-4737-6163 |
| authorships[9].author.display_name | Richard D. Kennedy |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Richard D. Kennedy |
| authorships[9].is_corresponding | False |
| authorships[10].author.id | https://openalex.org/A5038968301 |
| authorships[10].author.orcid | https://orcid.org/0000-0002-9920-514X |
| authorships[10].author.display_name | Ioannis Roxanis |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | Ioannis Roxanis |
| authorships[10].is_corresponding | False |
| authorships[11].author.id | https://openalex.org/A5034034892 |
| authorships[11].author.orcid | https://orcid.org/0000-0001-5031-1913 |
| authorships[11].author.display_name | Patrycja Gazińska |
| authorships[11].author_position | middle |
| authorships[11].raw_author_name | Patrycja Gazinska |
| authorships[11].is_corresponding | False |
| authorships[12].author.id | https://openalex.org/A5113139318 |
| authorships[12].author.orcid | https://orcid.org/0000-0002-1680-6530 |
| authorships[12].author.display_name | Sarah E. Pinder |
| authorships[12].author_position | middle |
| authorships[12].raw_author_name | Sarah E. Pinder |
| authorships[12].is_corresponding | False |
| authorships[13].author.id | https://openalex.org/A5006665510 |
| authorships[13].author.orcid | https://orcid.org/0000-0001-7957-7424 |
| authorships[13].author.display_name | Judith M. Bliss |
| authorships[13].author_position | middle |
| authorships[13].raw_author_name | Judith Bliss |
| authorships[13].is_corresponding | False |
| authorships[14].author.id | https://openalex.org/A5062498736 |
| authorships[14].author.orcid | https://orcid.org/0000-0001-9827-2247 |
| authorships[14].author.display_name | Charles M. Perou |
| authorships[14].author_position | middle |
| authorships[14].raw_author_name | Charles M. Perou |
| authorships[14].is_corresponding | False |
| authorships[15].author.id | https://openalex.org/A5052903538 |
| authorships[15].author.orcid | https://orcid.org/0000-0001-6685-5480 |
| authorships[15].author.display_name | Syed Haider |
| authorships[15].author_position | middle |
| authorships[15].raw_author_name | Syed Haider |
| authorships[15].is_corresponding | False |
| authorships[16].author.id | https://openalex.org/A5054103832 |
| authorships[16].author.orcid | https://orcid.org/0000-0003-3434-201X |
| authorships[16].author.display_name | Anita Grigoriadis |
| authorships[16].author_position | middle |
| authorships[16].raw_author_name | Anita Grigoriadis |
| authorships[16].is_corresponding | False |
| authorships[17].author.id | https://openalex.org/A5087121536 |
| authorships[17].author.orcid | https://orcid.org/0000-0001-8715-2901 |
| authorships[17].author.display_name | Andrew Tutt |
| authorships[17].author_position | middle |
| authorships[17].raw_author_name | Andrew Tutt |
| authorships[17].is_corresponding | False |
| authorships[18].author.id | https://openalex.org/A5019349196 |
| authorships[18].author.orcid | https://orcid.org/0000-0001-5718-2501 |
| authorships[18].author.display_name | Maggie C.U. Cheang |
| authorships[18].author_position | last |
| authorships[18].raw_author_name | Maggie Chon U. Cheang |
| authorships[18].is_corresponding | False |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://doi.org/10.1158/1078-0432.24145967.v1 |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Figure 5 from Integrated Multimodal Analyses of DNA Damage Response and Immune Markers as Predictors of Response in Metastatic Triple-Negative Breast Cancer in the TNT Trial (NCT00532727) |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T11287 |
| primary_topic.field.id | https://openalex.org/fields/13 |
| primary_topic.field.display_name | Biochemistry, Genetics and Molecular Biology |
| primary_topic.score | 0.9793999791145325 |
| primary_topic.domain.id | https://openalex.org/domains/1 |
| primary_topic.domain.display_name | Life Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/1306 |
| primary_topic.subfield.display_name | Cancer Research |
| primary_topic.display_name | Cancer Genomics and Diagnostics |
| related_works | https://openalex.org/W1481453705, https://openalex.org/W2057739827, https://openalex.org/W2099143831, https://openalex.org/W2054298289, https://openalex.org/W4231766842, https://openalex.org/W1624270399, https://openalex.org/W4238882508, https://openalex.org/W2170293083, https://openalex.org/W1961168765, https://openalex.org/W127700499 |
| cited_by_count | 0 |
| locations_count | 2 |
| best_oa_location.id | doi:10.1158/1078-0432.24145967.v1 |
| best_oa_location.is_oa | True |
| best_oa_location.source | |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | |
| best_oa_location.version | acceptedVersion |
| best_oa_location.raw_type | posted-content |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | False |
| best_oa_location.raw_source_name | |
| best_oa_location.landing_page_url | https://doi.org/10.1158/1078-0432.24145967.v1 |
| primary_location.id | doi:10.1158/1078-0432.24145967.v1 |
| primary_location.is_oa | True |
| primary_location.source | |
| primary_location.license | cc-by |
| primary_location.pdf_url | |
| primary_location.version | acceptedVersion |
| primary_location.raw_type | posted-content |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | False |
| primary_location.raw_source_name | |
| primary_location.landing_page_url | https://doi.org/10.1158/1078-0432.24145967.v1 |
| publication_date | 2023-09-15 |
| publication_year | 2023 |
| referenced_works_count | 0 |
| abstract_inverted_index.4 | 23 |
| abstract_inverted_index.6 | 25 |
| abstract_inverted_index.a | 2 |
| abstract_inverted_index.by | 8 |
| abstract_inverted_index.of | 1, 38, 44, 53, 70 |
| abstract_inverted_index.to | 30 |
| abstract_inverted_index.SI, | 47 |
| abstract_inverted_index.and | 11, 24 |
| abstract_inverted_index.are | 16, 26 |
| abstract_inverted_index.due | 29 |
| abstract_inverted_index.not | 27 |
| abstract_inverted_index.CNA; | 60, 64 |
| abstract_inverted_index.PGA, | 42 |
| abstract_inverted_index.copy | 66 |
| abstract_inverted_index.each | 39 |
| abstract_inverted_index.from | 18 |
| abstract_inverted_index.loss | 69 |
| abstract_inverted_index.NtAI, | 51 |
| abstract_inverted_index.exact | 20 |
| abstract_inverted_index.novel | 3, 9, 40 |
| abstract_inverted_index.rates | 7 |
| abstract_inverted_index.shown | 28 |
| abstract_inverted_index.small | 31 |
| abstract_inverted_index.AbCna, | 61 |
| abstract_inverted_index.AiCna, | 57 |
| abstract_inverted_index.CnLOH, | 65 |
| abstract_inverted_index.Fisher | 19 |
| abstract_inverted_index.genome | 45 |
| abstract_inverted_index.index; | 50 |
| abstract_inverted_index.number | 52, 67 |
| abstract_inverted_index.tests. | 21 |
| abstract_inverted_index.values | 15 |
| abstract_inverted_index.Heatmap | 34 |
| abstract_inverted_index.Shannon | 48 |
| abstract_inverted_index.allelic | 55, 58, 62 |
| abstract_inverted_index.groups. | 13 |
| abstract_inverted_index.neutral | 68 |
| abstract_inverted_index.showing | 35 |
| abstract_inverted_index.Clusters | 22 |
| abstract_inverted_index.Response | 6 |
| abstract_inverted_index.altered; | 46 |
| abstract_inverted_index.balanced | 63 |
| abstract_inverted_index.cluster. | 41 |
| abstract_inverted_index.clusters | 10 |
| abstract_inverted_index.features | 37 |
| abstract_inverted_index.numbers. | 32 |
| abstract_inverted_index.diversity | 49 |
| abstract_inverted_index.presented | 17 |
| abstract_inverted_index.telomeric | 54 |
| abstract_inverted_index.treatment | 12 |
| abstract_inverted_index.biological | 36 |
| abstract_inverted_index.imbalanced | 59 |
| abstract_inverted_index.percentage | 43 |
| abstract_inverted_index.clustering. | 4 |
| abstract_inverted_index.imbalances; | 56 |
| abstract_inverted_index.<p>Results | 0 |
| abstract_inverted_index.<i>P</i> | 14 |
| abstract_inverted_index.<b>A,</b> | 5 |
| abstract_inverted_index.<b>B,</b> | 33 |
| abstract_inverted_index.heterozygosity.</p> | 71 |
| cited_by_percentile_year | |
| countries_distinct_count | 0 |
| institutions_distinct_count | 19 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.7699999809265137 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.48194939 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |